Duke PA Students and Faculty Well Represented at Annual Conference
The Duke Physician Assistant (PA) Program was well represented at the American Academy of Physician Assistants’ (AAPA) 2022 conference, the first in-person conference since the beginning of the COVID-19 pandemic.
Newly Identified Aspect of Cell Death May Impact the Future of Fighting Diseases
Researchers have unmasked a component of the cell death process that could play a vital role in a better infection-fighting strategy.
The Perry Initiative: A Game Changer
For the past several years, Dr. Erickson has facilitated the Perry Initiative’s Outreach Program at Duke. This initiative provides a hands-on introduction to the field of Orthopaedic Surgery for women in medical school, engineering, and those still in high school.
Doctor of Physical Therapy Class of 2023 White Coat Ceremony
91 students made the transition from the classroom to their clinical experiences on Thursday, June 9, 2022, as members of the Duke Doctor of Physical Therapy Class of 2023 donned their wh
Duc Huynh Receives Ruth K. Broad Foundation Fellowship
Duc Huynh, a PhD student in the Department of Biochemistry, has received the Ruth K. Broad Foundation Fellowship for is plan to investigate glycobiology.
Duke Children’s Hospital Remains #1 in North Carolina for Pediatric Care
Duke Children’s Hospital & Health Center continues to rank as the No. 1 children’s hospital in North Carolina by U.S. News & World Report, with nine pediatric specialties ranked among the best in the nation.
2022 Michelle Winn Awards Celebrate Achievements in Diversity and Inclusion
Each year, the Winn Awards are presented to individuals from across the School of Medicine who have exemplified excellence, innovation, and leadership through helping to create a more diverse and inclusive environment.
Wingler Named a 2022 Pew Scholar
Laura Wingler, PhD, assistant professor of pharmacology and cancer biology, has been named a 2022 Pew Scholar in the Biomedical Sciences.
Study Finds No Benefit to Taking Ivermectin for COVID-19 Symptoms
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no differences in relief of mild-to-moderate COVID-19 symptoms between participants taking ivermectin and participants taking a placebo.